The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 28, 2023
Filed:
Aug. 19, 2019
Applicant:
Genmab A/s, Copenhagen V, DK;
Inventors:
Edward Norbert Van Den Brink, Halfweg, NL;
Joost J. Neijssen, Werkhoven, NL;
Aran Frank Labrijn, Utrecht, NL;
Joyce Meesters, Utrecht, NL;
Janine Schuurman, Utrecht, NL;
Isil Altintas, Utrecht, NL;
Paul Parren, Utrecht, NL;
Rik Rademaker, Utrecht, NL;
Assignee:
GENMAB A/S, Copenhagen V, DK;
Primary Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01); C07K 16/10 (2006.01); C07K 16/42 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2809 (2013.01); C07K 16/1063 (2013.01); C07K 16/2863 (2013.01); C07K 16/2887 (2013.01); C07K 16/2896 (2013.01); C07K 16/32 (2013.01); C07K 16/4241 (2013.01); G01N 33/6872 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/41 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/52 (2013.01); C07K 2317/524 (2013.01); C07K 2317/526 (2013.01); C07K 2317/53 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/71 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/74 (2013.01); C07K 2317/75 (2013.01); C07K 2317/90 (2013.01); C07K 2317/92 (2013.01); G01N 2333/7051 (2013.01);
Abstract
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.